A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients
Clinical trial NCT01650194 · COMPLETED
Trial details
- NCT number
- NCT01650194
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-09
- Primary completion
- 2018-01-04
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.